Author:
Meijer Suzy E.,Paran Yael,Belkin Ana,Ben-Ami Ronen,Maor Yasmin,Nesher Lior,Hussein Khetam,Rahav Galia,Brosh-Nissimov Tal
Reference42 articles.
1. SARS-CoV-2 in immunocompromised individuals;DeWolf;Immunity,2022
2. Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients treated with anti-CD20 monoclonal antibodies;Calderón-Parra;Clin Infect Dis,2022
3. Immunocompromised patients with protracted COVID-19: a review of “long persisters”;Dioverti;Curr Transplant Rep,2022
4. COVID-19 treatment guidelines panel. special considerations in people who are immunocompromised, in: Coronavirus disease 2019 (COVID-19) treatment guidelines
5. [cited 2023 Dec 31]. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/immunocompromised/.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献